Skip to main navigation Skip to search Skip to main content

Accuracy of Papanicolaou smears in cervical cancer patients treated with radiochemotherapy followed by radical surgery.

Research output: Contribution to journalArticle

Abstract

Papanicolaou (Pap) smears are part of the follow-up program for patients with cervical cancer treated with radiochemotherapy. After therapy, residual neoplastic cells may be rare, seldom exfoliate, and may demonstrate many alterations, which creates a risk of inaccurate results. We report a study of 65 patients who received radiochemotherapy before radical surgery. For each patient, we compared smear results with results from histologic examination of the whole cervix. The Pap smear was "negative for cancer" in 50 cases, "positive for cancer" in 6 cases, and detected atypical squamous cells of undetermined significance in 9 cases. Histologic examination revealed a complete pathologic response (pR0) in 26 cases and a partial pathologic response (pR1) in 27. In 12 cases, no pathologic response (pR2) was shown. Comparison of these results showed that the Pap test had a sensitivity of 0.16, a specificity of 0.96, a negative predictive value of 0.83, a positive predictive value of 0.42, and an accuracy of 0.46.
Original languageEnglish
Pages (from-to)787-794
Number of pages8
JournalAmerican Journal of Clinical Pathology
Publication statusPublished - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Papanicolaou smears
  • cervical cancer
  • radiochemotherapy

Fingerprint

Dive into the research topics of 'Accuracy of Papanicolaou smears in cervical cancer patients treated with radiochemotherapy followed by radical surgery.'. Together they form a unique fingerprint.

Cite this